British Society of Gastroenterology hepatocellular carcinoma guideline review: impact on the frontline
The British Society of Gastroenterology commissioned an update on the guidelines for management of hepatocellular carcinoma (HCC) in adults at an opportune time. The incidence of and mortality from this cancer is increasing in the UK, as in other Western nations. Several clinical and scientific advances in HCC have been made in the last decade. This article, written on behalf of the HCC-UK committee, provides a commentary on the guidelines, with specific focus on areas of practice change.
Authors
- M. Hawkins (ORCID: https://orcid.org/0000-0002-6669-0628)
- Ian Rowe (ORCID: https://orcid.org/0000-0003-1288-0749)
- Abid Suddle (ORCID: https://orcid.org/0000-0002-2415-5352)
- Dina Tiniakos (ORCID: https://orcid.org/0000-0003-4657-7780)
- Tim Meyer (ORCID: https://orcid.org/0000-0003-0782-8647)
- Teikchoon See
- Sarah Selemani
- Richard Hubner (ORCID: https://orcid.org/0000-0002-7081-8823)
- Helen L. Reeves (ORCID: https://orcid.org/0000-0003-0359-9795)
- Aileen Marshall (ORCID: https://orcid.org/0000-0003-3283-6315)
- Mark Callaway
Institutions
- University of Leeds (GB)
- Royal Free London NHS Foundation Trust (GB)
- Freeman Hospital (GB)
- Bristol Royal Infirmary (GB)
- The Christie NHS Foundation Trust (GB)
- CRUK Lung Cancer Centre of Excellence (GB)
- King's College Hospital (GB)
- Addenbrooke's Hospital (GB)
- University College London (GB)
- Newcastle University (GB)
Publication Details
- Journal
- Frontline Gastroenterology
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1136/flgastro-2024-102927
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00